UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Astrazeneca Plc ADR (AZN)

Astrazeneca Plc ADR (AZN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
66.29 +1.42 (+2.19%) 04/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 66.19 -0.10 (-0.15%) 16:53 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
64.45
Day High
66.62
Open 65.02
Previous Close 64.87 64.87
Volume 5,761,400 5,761,400
Avg Vol 6,614,505 6,614,505
Stochastic %K 32.56% 32.56%
Weighted Alpha -9.92 -9.92
5-Day Change -2.17 (-3.17%) -2.17 (-3.17%)
52-Week Range 61.24 - 87.68 61.24 - 87.68
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 205,579,488
  • Shares Outstanding, K 3,101,214
  • Annual Sales, $ 54,073 M
  • Annual Income, $ 7,035 M
  • EBIT $ 10,003 M
  • EBITDA $ 16,691 M
  • 60-Month Beta 0.49
  • Price/Sales 3.72
  • Price/Cash Flow 10.31
  • Price/Book 4.92

Options Overview Details

View History
  • Implied Volatility 36.33% ( -6.03%)
  • Historical Volatility 32.82%
  • IV Percentile 98%
  • IV Rank 65.21%
  • IV High 47.30% on 04/08/25
  • IV Low 15.77% on 05/28/24
  • Put/Call Vol Ratio 0.33
  • Today's Volume 2,971
  • Volume Avg (30-Day) 7,971
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 192,661
  • Open Int (30-Day) 184,113

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.10
  • Number of Estimates 5
  • High Estimate 1.14
  • Low Estimate 1.05
  • Prior Year 1.03
  • Growth Rate Est. (year over year) +6.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.24 +8.25%
on 04/09/25
Period Open: 74.24
77.76 -14.75%
on 03/17/25
-7.95 (-10.71%)
since 03/11/25
3-Month
61.24 +8.25%
on 04/09/25
Period Open: 67.01
78.36 -15.40%
on 03/05/25
-0.72 (-1.07%)
since 01/10/25
52-Week
61.24 +8.25%
on 04/09/25
Period Open: 69.45
87.68 -24.39%
on 08/30/24
-3.16 (-4.55%)
since 04/11/24

Most Recent Stories

More News
Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More

This week, the European Commission granted marketing authorization to the expanded use of AbbVie’s ABBV Rinvoq and AstraZeneca’s AZN blockbuster cancer drugs, Imfinzi and Daiichi-Sankyo partnered,...

AZN : 66.29 (+2.19%)
NVS : 107.52 (+3.98%)
ABBV : 175.05 (+0.49%)
Pharma Stocks Rebound as Trump Announces a 90-Day Pause on Tariffs

The stock market was on a roller coaster on April 9 amid the ongoing global trade war triggered by a new series of tariffs by the U.S. government. Most of the pharma bigwigs ended the trading session in...

AZN : 66.29 (+2.19%)
NVO : 64.73 (+5.75%)
LLY : 732.41 (+1.60%)
ABBV : 175.05 (+0.49%)
Stocks Spike as Trump Announces 90-Day Tariff Pause

The S&P 500 Index ($SPX ) (SPY ) today is up +5.99%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +3.96%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +7.05%. June E-mini S&P futures (ESM25...

ALK : 45.76 (+2.81%)
GOOGL : 157.14 (+2.83%)
MPC : 123.43 (+1.56%)
AAPL : 198.15 (+4.06%)
JNJ : 151.73 (+2.04%)
AMGN : 285.98 (+1.62%)
PFE : 21.91 (+1.48%)
OXY : 37.67 (+3.29%)
TSLA : 252.31 (-0.04%)
FANG : 129.01 (+4.75%)
AMD : 93.40 (+5.30%)
SPY : 533.94 (+1.78%)
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today

Might the tariff risk for pharmaceutical stocks be less than you think?

AZN : 66.29 (+2.19%)
LLY : 732.41 (+1.60%)
RHHBY : 38.1000 (+3.36%)
Stocks Supported by Strength in Megacap Technology and Airline Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.49%. June E-mini S&P futures (ESM25...

ALK : 45.76 (+2.81%)
GOOGL : 157.14 (+2.83%)
MPC : 123.43 (+1.56%)
AAPL : 198.15 (+4.06%)
ADI : 179.16 (+0.45%)
JNJ : 151.73 (+2.04%)
AMGN : 285.98 (+1.62%)
PFE : 21.91 (+1.48%)
OXY : 37.67 (+3.29%)
TSLA : 252.31 (-0.04%)
FANG : 129.01 (+4.75%)
AMD : 93.40 (+5.30%)
3 No-Brainer Growth Stocks to Buy for Less Than $100

Don't let the sell-off in the markets scare you off: Now may be an ideal time to buy stocks. Even if you don't have a lot of money that you can afford to invest, there are many great stocks you can buy...

ANET : 72.67 (+0.03%)
AZN : 66.29 (+2.19%)
UBER : 72.28 (+1.89%)
Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure

This week, the FDA approved Sanofi’s SNY hemophilia therapy, fitusiran, Novartis’ NVS Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) and the expanded...

AZN : 66.29 (+2.19%)
JNJ : 151.73 (+2.04%)
NVS : 107.52 (+3.98%)
PFE : 21.91 (+1.48%)
SNY : 51.50 (+3.71%)
Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday

As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on Wednesday decimated the stock market on Thursday. It had one of its worst trading...

AZN : 66.29 (+2.19%)
$SPX : 5,363.36 (+1.81%)
VEEV : 218.00 (+3.49%)
CPRX : 22.05 (+2.80%)
AMGN : 285.98 (+1.62%)
JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer

J&J JNJ recently reported new positive data from the phase III MARIPOSA study, which compared the combination of Rybrevant and Lazcluze against AstraZeneca’s AZN Tagrisso in first-line EGFR-mutated non-small...

AZN : 66.29 (+2.19%)
JNJ : 151.73 (+2.04%)
NVS : 107.52 (+3.98%)
Global Radiotherapy Market Expected to Reach $9.62 Billion By 2030 Realizing Growth Due to Technological Advancements

EQNX::TICKER_START (NYSE:ATNM),(NYSE:BMY),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AZN) EQNX::TICKER_END

AZN : 66.29 (+2.19%)
LLY : 732.41 (+1.60%)
NVS : 107.52 (+3.98%)
ATNM : 1.3000 (+13.04%)
BMY : 50.71 (+0.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition...

See More

Key Turning Points

3rd Resistance Point 69.30
2nd Resistance Point 67.96
1st Resistance Point 67.13
Last Price 66.29
1st Support Level 64.95
2nd Support Level 63.61
3rd Support Level 62.77

See More

52-Week High 87.68
Fibonacci 61.8% 77.58
Fibonacci 50% 74.46
Fibonacci 38.2% 71.34
Last Price 66.29
52-Week Low 61.24

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar